ArticlebioRxiv : the preprint server for biology2026
Engineering nanoparticle surface chemistry for antigen-presenting cell targeting improves specificity and safety of TLR3 agonist cancer immunotherapy.
Victoria F Gomerdinger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.